BR0014087A - Composições com pérolas de caroteno - xantofila estáveis e métodos de uso - Google Patents

Composições com pérolas de caroteno - xantofila estáveis e métodos de uso

Info

Publication number
BR0014087A
BR0014087A BR0014087-2A BR0014087A BR0014087A BR 0014087 A BR0014087 A BR 0014087A BR 0014087 A BR0014087 A BR 0014087A BR 0014087 A BR0014087 A BR 0014087A
Authority
BR
Brazil
Prior art keywords
methods
stable
xanthophyll
carotene
compositions
Prior art date
Application number
BR0014087-2A
Other languages
English (en)
Inventor
John C Lang
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23571337&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0014087(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0014087A publication Critical patent/BR0014087A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçõES COM PéROLAS DE CAROTENO-XANTOFILA ESTáVEIS E MéTODOS DE USO". São revelados pérolas contendo xantofilas e carotenos e/ou retinóides, suplementos dietéticos contendo essas pérolas e métodos de uso.
BR0014087-2A 1999-09-17 2000-09-06 Composições com pérolas de caroteno - xantofila estáveis e métodos de uso BR0014087A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/397,472 US6582721B1 (en) 1999-09-17 1999-09-17 Stable carotene-xanthophyll beadlet compositions and methods of use
PCT/US2000/024439 WO2001019383A1 (en) 1999-09-17 2000-09-06 Stable carotene-xanthophyll beadlet compositions and methods of use

Publications (1)

Publication Number Publication Date
BR0014087A true BR0014087A (pt) 2003-07-29

Family

ID=23571337

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014087-2A BR0014087A (pt) 1999-09-17 2000-09-06 Composições com pérolas de caroteno - xantofila estáveis e métodos de uso

Country Status (13)

Country Link
US (2) US6582721B1 (pt)
EP (1) EP1212071B1 (pt)
JP (1) JP2003516720A (pt)
AR (1) AR025247A1 (pt)
AT (1) ATE350062T1 (pt)
AU (1) AU780168B2 (pt)
BR (1) BR0014087A (pt)
CA (1) CA2382008A1 (pt)
DE (1) DE60032778T2 (pt)
HK (1) HK1048247B (pt)
MX (1) MXPA02001837A (pt)
TW (1) TWI232103B (pt)
WO (1) WO2001019383A1 (pt)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7239755B1 (en) * 1997-07-30 2007-07-03 Lg Electronics Inc. Method of reducing a blocking artifact when coding moving picture
US7115277B2 (en) * 1999-03-04 2006-10-03 Allergan, Inc. Method for enabling delivery of an active agent
US7416749B2 (en) * 2000-06-12 2008-08-26 Access Business Group International Llc Dietary supplement and related method
US7438936B2 (en) * 2000-06-12 2008-10-21 Access Business Group International Llc Dietary supplement and related method
WO2002005827A2 (en) * 2000-07-18 2002-01-24 Forum Bioscience Use of natural products in cancer treatment
US6660297B2 (en) * 2001-03-23 2003-12-09 Bausch & Lomb Incorporated Nutritional supplement to treat macular degeneration
US6773733B2 (en) * 2001-03-26 2004-08-10 Loders Croklaan Usa Llc Structured particulate systems
US20030008048A1 (en) * 2001-06-08 2003-01-09 David Winston Methods and compositions for helping the body resist the effects of the aging process
JP2003055188A (ja) * 2001-08-20 2003-02-26 Fuji Chem Ind Co Ltd シワ形成防止用皮膚外用剤、化粧料及び食品
US6811801B2 (en) * 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
US20040076691A1 (en) * 2002-01-16 2004-04-22 David Haines Anti-inflammatory formulations
US6663900B2 (en) * 2002-02-01 2003-12-16 Kemin Foods, Lc Microcapsules having high carotenoid content
DE60321669D1 (de) * 2002-03-28 2008-07-31 Alcon Inc Co-perlchen von dha und rosmarin und verwendungsverfahren
AR039170A1 (es) * 2002-03-28 2005-02-09 Bio Dar Ltd Co-granulos de dha y romero y metodos de uso
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
KR20030087566A (ko) * 2002-05-07 2003-11-14 액세스 비지니스 그룹 인터내셔날 엘엘씨 식물생리활성 영양 보조물
US6936279B2 (en) 2002-06-18 2005-08-30 Zeavision Llc Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations
US8148431B2 (en) 2002-10-25 2012-04-03 Kemin Health, L.C. Osteogenesis promoter containing β-cryptoxanthin as the active ingredient
EP1433387A1 (en) * 2002-12-26 2004-06-30 Adisseo France S.A.S. Solid granules containing carotenoids
DE20300305U1 (de) 2003-01-09 2003-04-24 Mann Gerhard Chem Pharm Fab Ocuvite Lutein
EP1635842A4 (en) * 2003-06-20 2007-04-04 Alcon Inc TREATMENT OF AMD WITH A COMBINATION OF INGREDIENTS
JP2005065525A (ja) * 2003-08-20 2005-03-17 Koyo Shokai:Kk ルテインおよびブルーベリー含有飲料
US7267830B2 (en) * 2003-12-19 2007-09-11 Alcon, Inc. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
DE20320101U1 (de) * 2003-12-23 2004-04-29 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Mikronährstoffkombinationsprodukt geeignet zur ergänzenden bilanzierten Diät bei altersbedingter Makuladegeneration
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
AR047658A1 (es) 2004-02-03 2006-02-01 Cargill Inc Concentrado de proteinas y corriente acuosa con carbohidratos hidrosolubles
FR2869503B1 (fr) * 2004-04-29 2008-01-18 Claude Bonne Compositions d'aliments fonctionnels destines a prevenir ou ralentir l'evolution de la degenerescence maculaire liee a l'age.
ES2351701T3 (es) * 2004-05-18 2011-02-09 Dsm Ip Assets B.V. USO DE ß-CRIPTOXANTINA.
DE202004010212U1 (de) * 2004-06-30 2004-09-23 Dr. Mann Pharma, Chem.-Pharm. Fabrik Gmbh Lutein-enthaltende Zusammensetzung
CN1984569B (zh) * 2004-07-21 2010-11-17 帝斯曼知识产权资产管理有限公司 4-酮基叶黄素的制备方法和其作为食品添加剂的用途
US20060134226A1 (en) * 2004-11-16 2006-06-22 Todd Leonard Compositions useful to treat ocular neovascular diseases and macular degeneration
US7981858B1 (en) 2004-12-22 2011-07-19 Alcon, Inc. Methods of using zinc containing compounds to improve ocular health
FR2883182B1 (fr) * 2005-03-16 2008-02-15 Novartis Ag Composition de vitamines utiles dans le traitement des maladies oculaires
US20070092578A1 (en) * 2005-10-26 2007-04-26 Yasuhiro Itagaki Skin rejuvinating supplement
US20070207116A1 (en) * 2006-03-01 2007-09-06 Brown David C Antioxidant compositions for the eye
US8278358B2 (en) * 2006-07-06 2012-10-02 Omnica Gmbh Lipoic acid derivatives
US7282225B1 (en) * 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
US20080181972A1 (en) * 2007-01-29 2008-07-31 Valentina Amico Compositions and Methods for Maintaining, Strengthening, Improving, or Promoting Eye Health
JP5376486B2 (ja) * 2007-01-30 2013-12-25 学校法人東京農業大学 クリキュラ繭由来のルテイン含有黄色色素の製造方法
JP5702514B2 (ja) * 2007-10-26 2015-04-15 丸善製薬株式会社 ルテインの光劣化に対する安定化方法
JP2009107945A (ja) * 2007-10-26 2009-05-21 Maruzen Pharmaceut Co Ltd 視神経障害抑制剤及びそれを含有する飲食品
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090181901A1 (en) * 2007-11-14 2009-07-16 Thomas Eidenberger Compositions and methods to increase bioavailability of carotenoids
CN101595977B (zh) * 2008-06-02 2013-04-03 浙江医药股份有限公司新昌制药厂 有益于眼睛明视持久度的配方食品及其应用
JP2010105984A (ja) * 2008-10-31 2010-05-13 Unitika Ltd 経口投与組成物
WO2010074940A1 (en) 2008-12-23 2010-07-01 Alcon Research, Ltd. Compositions and nutritional supplements for improving ocular health and reducing ocular inflammatory response
CN101519396B (zh) * 2009-03-09 2011-10-26 浙江华源制药科技开发有限公司 d-α生育酚琥珀酸酯提纯精制的方法
US20110021465A1 (en) * 2009-07-23 2011-01-27 U.S. Nutraceuticals, Llc D/B/A Valensa International Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome
US20130295171A1 (en) 2009-07-23 2013-11-07 U.S NUTRACEUTICALS, LLC d/b/a Valensa International Krill oil and reacted astaxanthin composition and associated method
US20110237548A1 (en) * 2009-07-23 2011-09-29 U.S. Nutraceuticals, Llc D/B/A Valensa International Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome using omega choline
US20130011469A1 (en) 2009-07-23 2013-01-10 U.S. Nutraceuticals, Llc D/B/A Valensa International Krill oil and carotenoid composition, associated method and delivery system
TWI669068B (zh) * 2009-08-12 2019-08-21 美商梅拉洛伊卡公司 抗氧化膳食補充組成物
EP2496233A1 (en) * 2009-11-06 2012-09-12 Alcon Research, Ltd. Nutritional supplements for relief of dry eye
CA2790097A1 (en) * 2010-03-05 2011-09-09 Ophthalmopharma Ag Nutraceutical chocolate or compound chocolate product
JP6026719B2 (ja) * 2010-08-31 2016-11-16 株式会社ダイセル 視機能予防・改善剤
BR112013027004B1 (pt) * 2011-04-20 2020-02-04 Dsm Ip Assets Bv processo de produção de microesferas compreendendo carotenoides e processo de produção de produto alimentar, ração ou de cuidado pessoal
WO2013043366A1 (en) * 2011-09-20 2013-03-28 Nestec S.A. Methods and compositions for improving visual function and eye health
JP5565780B2 (ja) * 2012-09-28 2014-08-06 学校法人東京農業大学 クリキュラ繭色素及びその用途
WO2015067707A1 (en) * 2013-11-07 2015-05-14 Dsm Ip Assets B.V. Process for the purification of astaxanthin
CN105705041B (zh) * 2013-11-07 2019-07-30 帝斯曼知识产权资产管理有限公司 纯化虾青素的方法
EP3514143A1 (en) * 2013-11-07 2019-07-24 DSM IP Assets B.V. Dietary supplements, oily suspensions and powdery formulations comprising synthetic food-grade astaxanthin
WO2015067706A1 (en) * 2013-11-07 2015-05-14 Dsm Ip Assets B.V. Process for the purification of astaxanthin
CN105705040B (zh) * 2013-11-07 2018-12-11 帝斯曼知识产权资产管理有限公司 纯化虾青素的方法
WO2015067709A1 (en) * 2013-11-07 2015-05-14 Dsm Ip Assets B.V. Process for the purification of astaxanthin
WO2015173603A1 (en) 2014-05-16 2015-11-19 Omniactive Health Technologies Limited Hydrophilic matrix beadlet compositions with enhanced bioavailability
JP6370612B2 (ja) * 2014-06-05 2018-08-08 株式会社ファンケル ジヒドロケルセチンとアスタキサンチン含有組成物
JP6267066B2 (ja) * 2014-06-20 2018-01-24 株式会社ファンケル 放出制御型ソフトカプセル剤
US20160007641A1 (en) * 2014-07-10 2016-01-14 Fmc Corporation Pigment Formulation
US9370503B1 (en) * 2015-02-26 2016-06-21 Chi Chou Liao Compounds for treating ocular diseases
JP6647809B2 (ja) * 2015-07-01 2020-02-14 株式会社東洋新薬 網膜保護組成物
JP2017025171A (ja) * 2015-07-17 2017-02-02 三栄源エフ・エフ・アイ株式会社 タブレット状可食性組成物
EP3490579B1 (en) 2016-07-27 2025-09-10 Hartis-Pharma SA Therapeutic combinations to treat red blood cell disorders
EP3721874B1 (en) * 2017-12-08 2022-05-18 Chenguang Biotech Group Co., Ltd. Lycopene micro-capsule powder and preparation method therefor

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2917539A (en) 1955-12-29 1959-12-15 Hoffmann La Roche Process for the manufacture of carotenoids
US3998753A (en) 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
CH627449A5 (de) 1977-03-25 1982-01-15 Hoffmann La Roche Verfahren zur herstellung von mikrokristallinem vitamin a-acetat, sowie von trockenen, frei-fliessenden praeparaten, in welchen vitamin a-acetat in mikrokristalliner form vorliegt.
DE3119383A1 (de) 1981-05-15 1982-12-02 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinodpraeparaten
US4670247A (en) 1983-07-05 1987-06-02 Hoffman-Laroche Inc. Process for preparing fat-soluble vitamin active beadlets
DE3611229A1 (de) 1986-04-04 1987-10-08 Basf Ag Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinoidpraeparaten
ATE96312T1 (de) 1989-07-25 1993-11-15 Hoffmann La Roche Verfahren zur herstellung von carotinoidpraeparaten.
DK0534955T3 (da) 1989-08-30 1997-10-13 Applied Food Biotech Inc Fremgangsmåde til fremstilling af en zeaxanthinholdig sammensætning under anvendelse af en mikroorganisme af arten Flavobacterium multivorum.
DK546289D0 (da) 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere
JPH06501695A (ja) 1990-10-01 1994-02-24 ブリガム・アンド・ウイメンズ・ホスピタル 主要血管事象を抑制するためのベータ−カロテン及びビタミンｅ療法
DE4141351A1 (de) 1991-12-14 1993-06-17 Basf Ag Stabile pulverfoermige vitamin- und/oder carotinoid-praeparate und verfahren zu deren herstellung
DE4200728A1 (de) 1992-01-14 1993-07-15 Basf Ag Stabile, fluessige praeparate fettloeslicher substanzen
EP0565989B1 (de) 1992-04-14 1997-06-25 F. Hoffmann-La Roche Ag Präparate von fettlöslichen Substanzen
GB9219524D0 (en) 1992-09-15 1992-10-28 Smithkline Beecham Plc Novel composition
FR2703263B1 (fr) 1993-03-31 1995-05-19 Rhone Poulenc Nutrition Animal Procédé de préparation de sphérules de principes actifs.
US5466599A (en) 1993-04-19 1995-11-14 Universal Foods Corporation Astaxanthin over-producing strains of phaffia rhodozyma
FR2707184B1 (fr) 1993-07-08 1995-08-11 Rhone Poulenc Nutrition Animal Procédé de préparation de sphérules contenant un principe actif alimentaire ou pharmaceutique.
US5382714A (en) 1994-03-17 1995-01-17 The Catholic University Of America Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof
US5527533A (en) 1994-10-27 1996-06-18 Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
JPH10511355A (ja) * 1994-12-22 1998-11-04 ヘンケル コーポレーション トコフェロールとベータ−カロチンの組成物
US5596011A (en) * 1995-04-06 1997-01-21 Repine; Karen M. Method for the treatment of macular degeneration
US5747544A (en) 1995-10-31 1998-05-05 Applied Food Biotechnology, Inc. Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans
US5648564A (en) 1995-12-21 1997-07-15 Kemin Industries, Inc. Process for the formation, isolation and purification of comestible xanthophyll crystals from plants
DE19609477A1 (de) 1996-03-11 1997-09-18 Basf Ag Stabile wäßrige Solubilisate von Carotinoiden und Vitamine
US5895652A (en) 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
TR199900610T2 (xx) 1996-09-20 1999-06-21 The Howard Foundation Polifenol i�eren terkiplerin �retim y�ntemi.
CA2280093A1 (en) 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
US5955102A (en) 1998-09-04 1999-09-21 Amway Corporation Softgel capsule containing DHA and antioxidants

Also Published As

Publication number Publication date
JP2003516720A (ja) 2003-05-20
TWI232103B (en) 2005-05-11
HK1048247A1 (en) 2003-03-28
CA2382008A1 (en) 2001-03-22
DE60032778T2 (de) 2007-11-08
MXPA02001837A (es) 2002-08-12
AU7117200A (en) 2001-04-17
US6716447B1 (en) 2004-04-06
ATE350062T1 (de) 2007-01-15
WO2001019383A1 (en) 2001-03-22
EP1212071A1 (en) 2002-06-12
US6582721B1 (en) 2003-06-24
HK1048247B (en) 2007-06-29
EP1212071B1 (en) 2007-01-03
DE60032778D1 (de) 2007-02-15
AR025247A1 (es) 2002-11-13
AU780168B2 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
BR0014087A (pt) Composições com pérolas de caroteno - xantofila estáveis e métodos de uso
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
BG103664A (en) Pharmaceutical forms containing ammoxycillin and clavulanate
CA2233108A1 (en) Complex of y-cyclodextrin and retinol or retinol derivatives, processes for their preparation and their use
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
DK367984A (da) Kosmetisk produkt indeholdende dimethylpolysiloxan
ATE198143T1 (de) Zahnpasten
PT1053256E (pt) Anticorpos para o receptor de morte 4 (dr4) e utilizações destes
MY119042A (en) Dolastatin derivatives, their preparation and use
AU7249198A (en) Substantially pure zonulin, a physiological modulator of mammalian tight junctions
TR200000152T2 (tr) Yeni bileşikler.
CA2268799A1 (fr) Derives biphenyliques substitues par un radical aromatique ou heteroaromatique et compositions pharmaceutiques et cosmetiques les contenant
MX9602445A (es) Pigmentos dorados.
CA2225903A1 (en) Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
DE60020738D1 (de) Teilchenförmige vitaminzubereitung
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
AU7027100A (en) Novel compounds
PL320500A1 (en) Cosmetic compositions exhibiting photoprotective properties and containing nanopigments, tio2 and an acylamino acid
AU2003222850A1 (en) Sunscreens
TR199701202T1 (xx) Yeni hidroksimik asit t�revleri.
TR200000371T2 (tr) 3-İkame edilen 3,4,5,7,- tetrahidro-pirrolo [3',4':4,5] tieno[2,3-D] pirimidin türevleri, üretimi ve 5HT-antagonistleri olarak kullanımları.
MD970269A (en) Clavulanates

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 35/78 , A23L 1/30 , A23L 1/303

Ipc: A61K 36/8962 (2006.01), A23L 1/30 (2006.01), A23L

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 11, 8O C/C 13, 10 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/52 (2006.01), A23L 33/105 (2016.01), A23L